Related Experiment Video
Updated: Oct 11, 2025
07:37
Label-free Neutrophil Enrichment from Patient-derived Airway Secretion Using Closed-loop Inertial Microfluidics
Published on: June 7, 2018
6.5K
Bridging micro/nano-platform and airway allergy intervention
Meng-Jie Sun1, Zhuang Teng1, Peng-Sheng Fan1
1College of Marine Life Science, Ocean University of China, Qingdao 266003, PR China.
Summary
Micro/nano therapeutic systems offer promising alternatives for treating allergic airway diseases. These advanced systems aim to overcome limitations of current intranasal treatments for conditions like asthma.
Area of Science:
- Pulmonary Medicine
- Nanotechnology
- Allergy and Immunology
Background:
- Allergic airway diseases are increasing due to industrialization and environmental factors.
- Current treatments like corticosteroids and antihistamines delivered intranasally have limitations including mucosal irritation and rapid drug dispersal.
- Intratracheal micro/nano therapeutic systems are emerging as innovative alternatives.
Purpose of the Study:
- To review the potential applications of micro/nano-platforms in treating airway allergic diseases.
- To discuss the use of micro/nano-platforms as carriers, therapeutic agents, and immunomodulators.
- To summarize challenges and future prospects of micro/nano-platforms for airway allergy.
Main Methods:
- Literature review of micro/nano-platform applications in airway allergy.
- Analysis of current drug delivery limitations for respiratory allergies.
- Exploration of micro/nano-systems for targeted intervention.
Main Results:
- Micro/nano-platforms show potential as carriers, therapeutic agents, and immunomodulators for airway allergies.
- These systems can potentially improve drug delivery efficacy and reduce side effects compared to conventional methods.
- Challenges remain in optimizing nasal delivery and system development.
Conclusions:
- Micro/nano therapeutic systems represent a significant advancement in managing allergic airway inflammation.
- These systems offer a promising future direction for more effective and targeted allergy interventions.
- Further development is needed to overcome existing challenges for clinical application.
Related Concept Videos
01:23Inhaled Medications
469
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
469
01:20Asthma: Pathogenesis and Management
815
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
815